Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-20

Clinical Trial Update: Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing boosted atazanavir-based regimens to current effective HAART regimens in pediatric HIV shows equivalence, with results posted after co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HAART (Highly Active Antiretroviral Therapy)
  • atazanavir-boosted regimens (atazanavir boosted)

Snippet

Sponsor: Phoenix Children's Hospital | Conditions: Pediatric HIV, HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2020-04-20